CO2 LASER

The carbon dioxide laser (CO2) was developed in the 1960’s and is still used in specialized medical applications today. The CO2 laser works especially well with skin deficiencies and has been used with extramammary Paget’s disease (EMPD) patients.

Ablation by CO2 laser can reduce the number of EMPD cells, however, many EMPD patients have found it to be insufficient in achieving complete remission. Scarring is also possible. Some EMPD patients have used a combination of CO2 laser and photodynamic therapy (PDT).

Depending upon the size of the EMPD area involved, some CO2 laser patients require an operating room with the procedure done under sedation.

Treatments for extramammary Paget’s disease (EMPD) often differ but frequently include one or more of the following: Mohs surgery, wide local excision (WLE) surgery, topical creams, carbon dioxide (CO2) laser, photodynamic therapy (PDT), cavitational ultrasonic surgical aspiration (CUSA), radiation therapy, skin grafts, and chemotherapy.

The content presented on this website, encompassing both textual material and visual media, serves educational and informational purposes aimed at aiding individuals affected by extramammary Paget’s disease (EMPD) and their families in comprehending the complexities associated with EMPD. It is imperative to note that the website is not designed to serve as a replacement for professional medical advice, diagnosis, or treatment. Furthermore, the website does not advocate for or endorse any specific treatments, tests, physicians, procedures, or products. Should you suspect that you are experiencing symptoms of EMPD, we strongly advise you to seek guidance from your healthcare provider.